University of Calgary
UofC Navigation

Brain and Mental Health

Submitted by mclean1 on Wed, 06/22/2016 - 1:48pm

Brain and Mental Health

Brain and Mental Health

Brain disorders are an increasing public health concern, surpassing both cardiovascular disease and cancer with respect to global burden of disease. These disorders have familiar names, including depression, multiple sclerosis, stroke, Alzheimer’s disease and many more. They have a devastating impact, not only to those afflicted, but also on families, the community and the health care system.

Launched in May 2015, the Brain and Mental Health research strategy provides a unifying direction for brain and mental health research at the University of Calgary. This exciting strategy, led by the Hotchkiss Brain Institute, positions University of Calgary researchers to unlock new discoveries and treatments for brain health in our community by working in interdisciplinary teams.

Read more about Brain and Mental Health research » 

Researchers identify drug that alleviates opioid withdrawal

Existing drug is effective in preventing withdrawal symptoms in opioid-dependent rodents

Opioid use and abuse is a significant social, health and economic issue in Canada. Researchers at the University of Calgary’s Faculty of Veterinary Medicine (UCVM) and Hotchkiss Brain Institute (HBI) at the Cumming School of Medicine (CSM) have discovered that an existing anti-gout medication is effective in reducing the severity of withdrawal symptoms in opioid-dependent rodents. Their work is leading to the development of a clinical trial at the Calgary Pain Clinic.

Neuroscientist Tuan Trang, PhD, and his team including PhD student Nicole Burma explored the underlying causes of opioid withdrawal and identified an important target in the spinal cord that is responsible for producing withdrawal symptoms in rats and mice. 
Read more »

Prominent neurobiologist appointed to direct national research initiative

Samuel Weiss to lead CIHR’s new Institute of Neurosciences, Mental Health and Addiction

Roderick McInnes, acting president of the Canadian Institutes of Health Research (CIHR) announced on May 3 the appointment of Samuel Weiss, PhD, as incoming scientific director of CIHR’s Institute of Neurosciences, Mental Health and Addiction (INMHA). This appointment will be effective July 1, 2017. 

Since 2004, Weiss has served as the inaugural director of the Hotchkiss Brain Institute (HBI) at the University of Calgary, where he leads a team of more than 750 members, trainees and staff. He is also a tenured professor in the departments of cell biology and anatomy, and physiology and pharmacology, at the University of Calgary’s Cumming School of Medicine. Read more

News & Events

UCalgary draws international recognition for industry links, high-impact research collaborations

Angelique Jenney sees her role as narrowing the gap between research and clinicians

New awards support research for energy transitions and improved health


IICD Research Strategy Strategic Research Plan Eyes High 2012 Academic Plan